Drug class · Oncology & immunology
Kinase inhibitors Drug Codes & NDCs
Small-molecule drugs that inhibit one or more protein kinases. Most are oral products dispensed by pharmacies.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Tofacitinib | Tofacitinib citrate 5 mg/1 | Tablet, Film coatedOral | AvKARE | 73190-100 |
| Tofacitinib | Tofacitinib citrate 10 mg/1 | Tablet, Film coatedOral | AvKARE | 73190-101 |
| Tofacitinib | Tofacitinib citrate 11 mg/1 | Tablet, Film coated, Extended releaseOral | AvKARE | 73190-102 |
| Tofacitinib | Tofacitinib citrate 11 mg/1 | Tablet, Film coated, Extended releaseOral | Exelan pharmaceuticals,Inc | 76282-816 |
| Tofacitinib | Tofacitinib citrate 11 mg/1 | Tablet, Film coated, Extended releaseOral | Orient Pharma Co., Ltd. Yunlin Plant | 76333-111 |
| Tofacitinib | Tofacitinib 5 mg/1 | Tablet, Film coatedOral | Golden State Medical Supply, Inc. | 84677-054 |
| Tofacitinib | Tofacitinib 10 mg/1 | Tablet, Film coatedOral | Golden State Medical Supply, Inc. | 84677-055 |
| Tofacitinib Citrate | Tofacitinib citrate 11 mg/1 | Tablet, Film coated, Extended releaseOral | Padagis US LLC | 0574-1811 |
| Tofacitinib Citrate | Tofacitinib citrate 11 mg/1 | Tablet, Film coated, Extended releaseOral | ScieGen Pharmaceuticals, INC. | 50228-567 |
| Tofacitinib Citrate | Tofacitinib citrate 11 mg/1 | Tablet, Film coated, Extended releaseOral | Radha Pharmaceuticals, Inc. | 77771-567 |
| Tofacitinib Citrate | Tofacitinib citrate 8.08 mg/1 | Tablet, Film coatedOral | Stellon Biotech Inc. | 85972-121 |
| Tofacitinib Citrate | Tofacitinib citrate 16.16 mg/1 | Tablet, Film coatedOral | Stellon Biotech Inc. | 85972-122 |
| tofacitinib solutiontofacitinib | Tofacitinib citrate 1 mg/mL | SolutionOral | Hikma Pharmaceuticals USA Inc. | 0054-0821 |
| Tofacitinib XRtofacitinib | Tofacitinib citrate 11 mg/1 | Tablet, Film coated, Extended releaseOral | Biocon Pharma Inc | 70377-057 |
| Torpenzeverolimus | Everolimus 2.5 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 0245-0822 |
| Torpenzeverolimus | Everolimus 5 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 0245-0823 |
| Torpenzeverolimus | Everolimus 7.5 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 0245-0824 |
| Torpenzeverolimus | Everolimus 10 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 0245-0825 |
| Tukysatucatinib | Tucatinib 50 mg/1 | TabletOral | SEAGEN INC. | 51144-001 |
| Tukysatucatinib | Tucatinib 150 mg/1 | TabletOral | SEAGEN INC. | 51144-002 |
| Turaliopexidartinib hydrochloride | Pexidartinib hydrochloride 125 mg/1 | CapsuleOral | Daiichi Sankyo Inc. | 65597-407 |
| Tykerblapatinib | Lapatinib ditosylate 250 mg/1 | TabletOral | Novartis Pharmaceuticals Corporation | 0078-0671 |
| Vanflytaquizartinib | Quizartinib dihydrochloride 17.7 mg/1 | Tablet, Film coatedOral | Daiichi Sankyo Inc. | 65597-504 |
| Vanflytaquizartinib | Quizartinib dihydrochloride 26.5 mg/1 | Tablet, Film coatedOral | Daiichi Sankyo Inc. | 65597-511 |
| Verzenioabemaciclib | Abemaciclib 50 mg/1 | TabletOral | Eli Lilly and Company | 0002-4483 |